-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Upgrades Solventum to Overweight, Raises Price Target to $87

Benzinga·05/19/2025 17:50:55
Listen to the news
Piper Sandler analyst Jason Bednar upgrades Solventum (NYSE:SOLV) from Neutral to Overweight and raises the price target from $78 to $87.